Isotretinoin Beyond the Skin: A Prospective Study on Its Impact on Periodontal Health
Keywords:
Isotretinoin, Periodontal Health, Bleeding on Probing, Plaque Index, Probing DepthAbstract
Background: Isotretinoin is a systemic retinoid widely used for the treatment of severe acne vulgaris. While its dermatologic side effects are well known, its potential impact on periodontal health has not been fully elucidated.
Objective: This prospective study aimed to evaluate the effects of systemic isotretinoin therapy on clinical periodontal parameters in young adults treated for acne vulgaris.
Methods: A total of 80 patients (59 females and 21 males), aged between 18 and 25 years, undergoing systemic isotretinoin therapy (0.5 mg/kg/day for months 0–3 and 0.7 mg/kg/day for months 4–6) for a duration of six months, were included in the study. Clinical periodontal assessments, including bleeding on probing (BOP), plaque index (PI), and probing depth (PD), were performed at baseline and after six months. Patients with systemic conditions, recent dental treatments or antibiotic use, and other potential confounding factors were excluded. Data were analyzed using the Wilcoxon signed-rank test, McNemar test, and regression analysis.
Results: Posttreatment assessments showed a significant increase in the prevalence of BOP (from 18.8% to 48.8%, P<0.001). The mean PI increased from 1.06 ± 1.24 to 1.26 ± 1.25 (P=0.007), while the mean PD rose from 1.25 ± 1.06 mm to 1.73 ± 1.08 mm (P<0.001). No significant association was found between changes in periodontal parameters and age or sex, as determined by regression analysis.
Conclusion: Isotretinoin therapy may contribute to subclinical deterioration in periodontal health, as evidenced by increased BOP, PI, and PD values. Although these changes were modest, clinicians prescribing isotretinoin should consider potential oral health implications and advise patients accordingly. For dermatologists, incorporating basic periodontal screening into routine care may help identify at-risk patients early.
References
Van Steensel MAM. The genetics of acne. Ann Hum Genet. 2025 Jul 21. DOI: 10.1111/ahg.70014
Saurat JH, Halioua B, Baissac C, et al. Epidemiology of acne and rosacea: A worldwide global study. J Am Acad Dermatol. 2024 May;90(5):1016-1018. DOI: 10.1016/j.jaad.2023.12.038
Cong TX, Hao D, Wen X, Li XH, He G, Jiang X. From pathogenesis of acne vulgaris to anti-acne agents. Arch Dermatol Res. 2019 Jul;311(5):337-349. DOI: 10.1007/s00403-019-01908-x
Bagatin E, Costa CS. The use of isotretinoin for acne - an update on optimal dosing, surveillance, and adverse effects. Expert Rev Clin Pharmacol. 2020 Aug;13(8):885-897. DOI: 10.1080/17512433.2020.1796637
Mohsin N, Hernandez LE, Martin MR, Does AV, Nouri K. Acne treatment review and future perspectives. Dermatol Ther. 2022 Sep;35(9):e15719. DOI: 10.1111/dth.15719
Paichitrojjana A, Paichitrojjana A. Oral Isotretinoin and Its Uses in Dermatology: A Review. Drug Des Devel Ther. 2023 Aug 25;17:2573-2591. DOI: 10.2147/DDDT.S427530
Sadeghzadeh-Bazargan A, Ghassemi M, Goodarzi A, Roohaninasab M, Najar Nobari N, Behrangi E. Systematic review of low-dose isotretinoin for treatment of acne vulgaris: Focus on indication, dosage, regimen, efficacy, safety, satisfaction, and follow up, based on clinical studies. Dermatol Ther. 2021 Jan;34(1):e14438. DOI: 10.1111/dth.14438
Dispenza MC, Wolpert EB, Gilliland KL, et al. Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. J Invest Dermatol. 2012 Sep;132(9):2198-205. DOI: 10.1038/jid.2012.111
Dessinioti C, Zouboulis CC, Bettoli V, Rigopoulos D. Comparison of guidelines and consensus articles on the management of patients with acne with oral isotretinoin. J Eur Acad Dermatol Venereol. 2020 Oct;34(10):2229-2240. DOI: 10.1111/jdv.16430
Brelsford M, Beute TC. Preventing and managing the side effects of isotretinoin. Semin Cutan Med Surg. 2008 Sep;27(3):197-206. DOI: 10.1016/j.sder.2008.07.002
Brzezinski P, Borowska K, Chiriac A, Smigielski J. Adverse effects of isotretinoin: A large, retrospective review. Dermatol Ther. 2017 Jul;30(4). DOI: 10.1111/dth.12483
Leyden JJ, James WD. Staphylococcus aureus infection as a complication of isotretinoin therapy. Arch Dermatol. 123:606-608, 1987 13.
Exner JH, Dahod S, Pochi PE.Pyogenic granuloma-like acne lesions during isotretinoin therapy. Arch Dermatol. 1983;119:808-811.
Ruchitha S, Gupta N, Singh K. Exploring the multifaceted side effects of isotretinoin: a deep dive into case reports and observational studies. Arch Dermatol Res. 2025 Feb 26;317(1):499. DOI: 10.1007/s00403-025-04019-y
Heitz-Mayfield LJA. Conventional diagnostic criteria for periodontal diseases (plaque-induced gingivitis and periodontitis). Periodontol 2000. 2024 Jun;95(1):10-19. DOI: 10.1111/prd.12579
Ito H, Numabe Y, Hashimoto S, et al. Correlation Between Gingival Crevicular Fluid Hemoglobin Content and Periodontal Clinical Parameters. J Periodontol. 2016 Nov;87(11):1314-1319. DOI: 10.1902/jop.2016.160092
Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condtion. Acta Odontol Scand. 1964 Feb;22:121-35. DOI: 10.3109/00016356408993968
Loe H. The gingival index, the plaque index and the retention index Systems. J Periodonto.l 1967;38:Suppl:610-6.
AlJasser R, AlAqeely R, AlKenani M, AlQahtani S, AlZahrani A, Lambarte R. The effect of systemic Isotretinoin on salivary tissue inhibitors of metalloproteinases 1 and 2 and salivary flow rate in periodontal disease. Saudi J Biol Sci. 2022 Jan;29(1):148-153. DOI: 10.1016/j.sjbs.2021.08.079
AlJasser RN, Alaqeely RS, Al-Hoqail IA, et al. Association between isotretinoin (Roaccutanne) use and changes in periodontal clinical parameters and MMP-8 and MMP-9 salivary levels. Front Biosci (Landmark Ed). 2021 Jul 30;26(7):191-197. DOI: 10.52586/4933
AlJasser R, AlAqeely R, AlZahrani A, et al. Antimicrobial Effect of Isotretinoin Therapy on Periodontal Pathogens: A Case-Control Study. Antibiotics (Basel). 2021 Oct 21;10(11):1286. DOI: 10.3390/antibiotics10111286
Mahajan A, Bharadwaj A, Mahajan P. Non‐Plaque‐Induced Gingivitis Associated With Isotretinoin: A Case Report. Clin adv periodontics. 2011;1(3):205- 9.
Shibuya N, Nemoto E, Kanaya S, Kunii R, Shimauchi H. Retinoic acid is a potential negative regulator for differentiation of human periodontal ligament cells. J Periodontal Res. 2005 Dec;40(6):432-440. DOI: 10.1111/j.1600-0765.2005.00811.x
Ustaoğlu G, Güler Ş, Polat M. Effect of isotretinoin on periodontal tissues and oxidative stress markers in the saliva. Turkderm-Turk Arch Dermatol Venereol. 2020;54(4):132-137. DOI:10.4274/turkderm.galenos.2020.99896
Yorulmaz Demir A, Metin A, Işıkoğlu S, Erel Ö. The effect of isotretinoin on oxidative stress in severe acne vulgaris patients. Turkiye Klinikleri J Med Sci. 2012;32:1026-1031.
Lynge Pedersen AM, Belstrøm D. The role of natural salivary defences in maintaining a healthy oral microbiota. J Dent. 2019 Jan;80 Suppl 1:S3-S12. DOI: 10.1016/j.jdent.2018.08.010
Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J. 1996 Jul;10(9):1002-13. DOI: 10.1096/fasebj.10.9.8801161
Kautsky MB, Fleckman P, Dale BA. Retinoic acid regulates oral epithelial differentiation by two mechanisms. J Invest Dermatol. 1995 Apr;104(4):546-53. DOI: 10.1111/1523-1747.ep12606058
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Funda Erduran, Mehmet Doğuhan Çoşlu, Seyhan Karaaslan, Selma Emre
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
